Summary & Overview
CPT 32491: Resection of Emphysematous Lung Tissue via Sternal or Transthoracic Approach
CPT code 32491 denotes surgical resection of diseased emphysematous lung tissue performed via a sternal split or transthoracic approach. This thoracic surgical procedure is used to remove nonfunctional, hyperinflated lung segments in patients with advanced emphysema or localized disease contributing to respiratory symptoms. Nationally, the code is relevant for hospitals and surgical practices that provide thoracic surgery and for payers managing coverage of advanced pulmonary interventions.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise outline of clinical context for the procedure, typical sites of service, and the payer landscape relevant to the code. The publication provides benchmarks and utilization context where available, summarizes common billing considerations, and highlights recent policy or coverage developments affecting surgical management of emphysema.
The content is intended to inform coding professionals, revenue cycle staff, and policy analysts about the clinical scope of the code, billing context, and payer coverage considerations at a national level. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 32491 describes the surgical removal of diseased emphysematous lung tissue performed through a sternal split or transthoracic approach. This procedure targets emphysematous portions of the lung that are causing respiratory compromise or recurrent complications.
-
Service type: Surgical resection of emphysematous lung tissue
-
Typical site of service: Inpatient or outpatient surgical setting with access via sternal split or transthoracic incision (thoracic operating room)
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with long-standing tobacco-related emphysema presents with progressive dyspnea, frequent exacerbations, and hyperinflation on pulmonary function testing despite optimal medical therapy. Imaging (high-resolution CT) demonstrates heterogeneous upper-lobe predominant emphysematous destruction with relatively preserved surrounding lung — anatomy favorable for surgical volume reduction. The thoracic surgery team evaluates perioperative risk, coordinates preoperative pulmonary rehabilitation and optimization, and discusses risks and benefits with the patient. The patient is scheduled for surgical lung volume reduction via open approach through a median sternotomy or transthoracic incision when minimally invasive access is not feasible or when bilateral access is required. Intraoperative steps include general endotracheal anesthesia, single-lung ventilation as tolerated, exposure via sternal split or thoracotomy, surgical resection of emphysematous lung segments (bullectomy/volume reduction), hemostasis, chest tube placement, and closure. Postoperative care includes ventilatory support as needed, chest tube management, pain control, early mobilization, pulmonary toilet, and monitoring for complications such as air leak, pneumonia, bleeding, or respiratory failure. Discharge planning includes outpatient pulmonary follow-up and possible pulmonary rehabilitation continuation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier required (placeholder in some payor systems) | Rarely appended; use per payer guidance when a default two-character modifier is required. |